In this study we found that Bcl-3 promotes TNF-induced hepatocyte apoptosis by enhanced RIP1 deubiquitination, providing a novel Bcl-3-targeted strategy for various liver diseases. The gene discussed is RIPK1; the disease is liver disorder.